Your browser doesn't support javascript.
loading
Leave no one behind: A global survey of the current state of geriatric oncology practice by SIOG national representatives.
Mizutani, Tomonori; Cheung, Kwok-Leung; Hakobyan, Yervand; Lane, Heather; Decoster, Lore; Karnakis, Theodora; Puts, Martine; Calderon, Oscar; Jørgensen, Trine L; Boulahssass, Rabia; Wedding, Ulrich; Karampeazis, Athanasios; Chan, Wendy Wing Lok; Banerjee, Joyita; Falci, Cristina; van Leeuwen, Barbara L; Fonseca, Vasco; Gironés Sarrió, Regina; Vetter, Marcus; Dougoud, Vérène; Naeim, Arash; Ashman, Jed; Musolino, Najia; Kanesvaran, Ravindran.
Afiliação
  • Mizutani T; Kyorin University Faculty of Medicine, Department of Medical Oncology, Tokyo, Japan. Electronic address: tomomizu@ks.kyorin-u.ac.jp.
  • Cheung KL; School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Hakobyan Y; Hematology Center after Prof. Yeolyan, Hematology and Transfusion Medicine department of NIH Armenia, Yerevan, Armenia.
  • Lane H; Sir Charles Gairdner Hospital, Geriatric and Rehabilitation Medicine Department, Perth, Australia.
  • Decoster L; UZ Brussel, Vrije Universiteit Brussel, Department of Medical Oncology, Brussels, Belgium.
  • Karnakis T; The Cancer Institute of the State of São Paulo/University, Division of Geriatric Medicine, São Paulo, Brazil.
  • Puts M; University of Toronto, Lawrence S. Bloomberg Faculty of Nursing, Toronto, Canada.
  • Calderon O; Clínica Alemana de Santiago and Complejo Asistencial Dr. Sótero del Río, Department of Geriatric Medicine, Santiago, Chile.
  • Jørgensen TL; Odense University Hospital, Department of Oncology, Odense, Denmark.
  • Boulahssass R; University Hospital of Nice, Geriatric Department, Nice, France.
  • Wedding U; University Hospital Jena, Department of Palliative Care, Jena, Germany.
  • Karampeazis A; The NIMTS Veterans Hospital, Medical Oncology Unit, Athens, Greece.
  • Chan WWL; Department of Clinical Oncology, The University of Hong Kong, China.
  • Banerjee J; All India Institute of Medical Sciences, Department of Geriatric Medicine, New Delhi, India.
  • Falci C; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.
  • van Leeuwen BL; University medical center Groningen, Department of Surgery, Groningen, the Netherlands.
  • Fonseca V; Centro Hospitalar de Lisboa Ocidental, Department of Oncology, Lisboa, Portugal.
  • Gironés Sarrió R; Hospital Universitari i Politècnic La FE, Department of Medical Oncology, Valencia, Spain.
  • Vetter M; Affiliation Cancer Center Baselland, Kantonsspital Baselland, Liestal, Switzerland.
  • Dougoud V; The HFR Hospital, Department of Medical Oncology, Fribourg, Switzerland.
  • Naeim A; UCLA and Samueli School of Engineering and Applied Science, Departments of Medicine and Bioengineering, Calfornia, United States.
  • Ashman J; Sandwell and West Birmingham NHS Trust, Birmingham City Hospital, Birmingham, United Kingdom; International Society of Geriatric Oncology, Geneva, Switzerland.
  • Musolino N; International Society of Geriatric Oncology, Geneva, Switzerland.
  • Kanesvaran R; National Cancer Centre Singapore, Department of Medical Oncology, Singapore, Singapore.
J Geriatr Oncol ; 15(2): 101709, 2024 03.
Article em En | MEDLINE | ID: mdl-38310661
ABSTRACT

INTRODUCTION:

The Sustainable Development Goals of the United Nations include a commitment to "leave no one behind" as a universal goal. To achieve this in geriatric oncology (GO) worldwide, it is important to understand the current state of GO at an international level. The International Society of Geriatric Oncology (SIOG) has several National Representatives (NRs) who act as SIOG's delegates in their respective countries. The NRs took part in this international survey exploring the state of GO practice, identifying barriers and solutions. MATERIALS AND

METHODS:

The NRs answered open-ended questions by email from February 2020 to October 2022. The questionnaire domains included the demographic information of older adults for their countries, and the NRs' opinions on whether GO is developing, what the barriers are to developing GO, and proposed actions to remove these barriers. The demographic data of each country reported in the survey was adjusted using literature and database searches.

RESULTS:

Twenty-one of thirty countries with NRs (70%) participated in this questionnaire study 12 European, four Asian, two North American, two South American, and one Oceanian. The proportion of the population aged ≥75 years varied from 2.2% to 15.8%, and the average life expectancy also varied from 70 years to 86 years. All NRs reported that GO was developing in their country; four NRs (18%) reported that GO was well developed. Although all NRs agreed that geriatric assessment was useful, only three reported that it was used day-to-day in their countries' clinical practice (14%). The major barriers identified were the lack of (i) evidence to support GO use, (ii) awareness and interest in GO, and (iii) resources (time, manpower, and funding). The major proposed actions were to (i) provide new evidence through clinical trials specific for GO patients, (ii) stimulate awareness through networking, and (iii) deliver educational materials and information to healthcare providers and medical students.

DISCUSSION:

This current survey has identified the barriers to GO and proposed actions that could remove them. Broader awareness seems to be essential to implementing GO. Additional actions are needed to develop GO within countries and can be supported through international partnerships.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Avaliação Geriátrica / Neoplasias Limite: Aged / Humans Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Avaliação Geriátrica / Neoplasias Limite: Aged / Humans Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2024 Tipo de documento: Article